Balance Sheet
Accounts PayablesCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Other Non-Current Liabilities: 2018-2025

Historic Other Non-Current Liabilities for Dr Reddys Laboratories (RDY) over the last 8 years, with Mar 2025 value amounting to $39.0 million.

  • Dr Reddys Laboratories' Other Non-Current Liabilities fell 18.75% to $39.0 million in Q1 2025 from the same period last year, while for Mar 2025 it was $39.0 million, marking a year-over-year decrease of 18.75%. This contributed to the annual value of $39.0 million for FY2025, which is 18.75% down from last year.
  • As of FY2025, Dr Reddys Laboratories' Other Non-Current Liabilities stood at $39.0 million, which was down 18.75% from $48.0 million recorded in FY2024.
  • In the past 5 years, Dr Reddys Laboratories' Other Non-Current Liabilities ranged from a high of $48.0 million in FY2024 and a low of $32.0 million during FY2021.
  • Over the past 3 years, Dr Reddys Laboratories' median Other Non-Current Liabilities value was $39.0 million (recorded in 2025), while the average stood at $40.7 million.
  • Per our database at Business Quant, Dr Reddys Laboratories' Other Non-Current Liabilities spiked by 37.14% in 2024 and then decreased by 18.75% in 2025.
  • Over the past 5 years, Dr Reddys Laboratories' Other Non-Current Liabilities (Yearly) stood at $32.0 million in 2021, then remained steady at $32.0 million in 2022, then climbed by 9.38% to $35.0 million in 2023, then spiked by 37.14% to $48.0 million in 2024, then dropped by 18.75% to $39.0 million in 2025.